Evommune Inc (EVMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 44,063 | 16,255 |
| Marketable Securities | 105,137 | 55,785 |
| TOTAL | $153,478 | $73,988 |
| Non-Current Assets | ||
| PPE Net | 994 | 1,326 |
| Investments And Advances | 67,489 | 0 |
| Other Non-Current Assets | 2,985 | 741 |
| TOTAL | $71,468 | $2,067 |
| Total Assets | $224,946 | $76,055 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 7,756 | 8,264 |
| Accrued Expenses | 9,547 | 6,729 |
| Other current liabilities | 364 | 9,501 |
| TOTAL | $17,909 | $27,981 |
| Non-Current Liabilities | ||
| Deferred Revenues | N/A | 3,000 |
| Other Non-Current Liabilities | 1,290 | 0 |
| TOTAL | $1,471 | $535 |
| Total Liabilities | $19,380 | $28,516 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 36,018 | N/A |
| Common Shares | 3 | N/A |
| Retained earnings | -221,089 | -152,219 |
| TOTAL | $205,566 | $47,539 |
| Total Liabilities And Equity | $224,946 | $76,055 |